Atria Wealth Solutions’s Galectin Therapeutics GALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-186,000
| Closed | -$227K | – | 1624 |
|
|
2025
Q1 | $227K | Sell |
186,000
-21,100
| -10% | -$25.7K | ﹤0.01% | 1642 |
|
|
2024
Q4 | $267K | Hold |
207,100
| – | – | ﹤0.01% | 1603 |
|
|
2024
Q3 | $570K | Sell |
207,100
-6,700
| -3% | -$18.4K | 0.01% | 1174 |
|
|
2024
Q2 | $483K | Sell |
213,800
-1,000
| -0.5% | -$2.26K | 0.01% | 1244 |
|
|
2024
Q1 | $513K | Sell |
214,800
-35,000
| -14% | -$83.7K | 0.01% | 1242 |
|
|
2023
Q4 | $415K | Sell |
249,800
-10,000
| -4% | -$16.6K | 0.01% | 1299 |
|
|
2023
Q3 | $499K | Sell |
259,800
-1,000
| -0.4% | -$1.92K | 0.01% | 1122 |
|
|
2023
Q2 | $376K | Sell |
260,800
-2,500
| -0.9% | -$3.6K | 0.01% | 1302 |
|
|
2023
Q1 | $553K | Sell |
263,300
-7,400
| -3% | -$15.5K | 0.01% | 1070 |
|
|
2022
Q4 | $306K | Sell |
270,700
-8,000
| -3% | -$9.04K | ﹤0.01% | 1341 |
|
|
2022
Q3 | $454K | Sell |
278,700
-3,000
| -1% | -$4.89K | 0.01% | 1068 |
|
|
2022
Q2 | $369K | Sell |
281,700
-4,000
| -1% | -$5.24K | 0.01% | 1090 |
|
|
2022
Q1 | $460K | Buy |
+285,700
| New | +$460K | 0.01% | 1109 |
|